Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

NCT00216398 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Lanreotide (Autogel formulation)

Sponsor

Ipsen